“It is important to recognize that nutrition and fitness have metabolic effects to decrease tissue AMPK activity that are quite pertinent to gout,” Dr. Terkeltaub said. Dietary and alcohol excesses, obesity, diabetes and poor physical fitness all have an effect, whereas nutritional constraint and physical fitness will elevate AMPK activity. Beyond colchicine, several drugs already in the clinic have the potential to limit innate immune inflammation, in large part, by activating AMPK. Those include methotrexate, nonacetylated salicylates, high-dose aspirin and metformin. “There is substantial potential for natural and pharmacologic means to limit harmful innate immune responses more safely and effectively by increasing tissue AMPK activity, such as in gout, osteoarthritis and certain other chronic joint diseases.”
You Might Also Like
Explore This IssueMarch 2015
Also By This Author
Kathy L. Holliman, MEd, is a medical writer based in Beverly, Mass.
If you missed this session, Innate Immunity at the Core of Rheumatic Disease, it’s not too late. Catch it on SessionSelect: http://acr.peachnewmedia.com/store/provider/provider09.php.
- Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1977;20(1):7–17.
- Steere AC, Broderick TF, Malawista SE. Erythema chronic migrans and Lyme arthritis: Epidemiologic evidence for a tick vector. Am J Epidemiol. 1978;108(4):312–321.
- Malawista SE, de Boisfleury AC, Naccache PH. Inflammatory gout: Observations over a half-century. FASEB J.2011;25(12):4073–4078.
- Dalbeth N, Pool B, Gamble GD, et al. Cellular characterization of the gouty tophus. Arthritis Rheum. 2010;62(5):1549–1556.
- Schauer C, Janko C, Munoz LE, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20(5):511–517.
- Zhao X, Petursson F, Viollet B, Lotz M, et al. Peroxisome proliferator-activated receptor γ coactivator 1α and FoxO3A mediate chondroprotection by AMP-activated protein kinase. Arthritis Rheumatol. 2014;66(11):3073–3082.
- Wang Y, Viollet B, Terkeltaub R, Liu-Bryan R. AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages. Ann Rheum Dis. 2014. doi: 10.1136/annrheumdis-2014-206074 [Epub ahead of print].